Cordis Corporation Launches Family of REGATTA(TM) Steerable Guidewires |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Cordis Corp.
14201 N.W. 60th Ave.
Hialeah, FL, 33014
USA
Press release date: February 26, 2007
WATERLOO, Belgium, February 26/- Company Expands Product Portfolio to Support Interventional Physicians and Patients
Cordis Corporation, a worldwide leader in developing and manufacturing interventional vascular technology, has announced the launch of the REGATTA(TM) Steerable Guidewire family in EMEA region. The company is this week introducing six selections of the REGATTA(TM) Steerable Guidewire and the REGATTA(TM) SB Steerable Guidewire. Later this year, the company will add the REGATTA(TM) HS Steerable Guidewire.
Cordis is offering the REGATTA(TM) Guidewire family to provide tailored solutions for the placement of catheters and other interventional devices in coronary arteries. The REGATTA(TM) Guidewires are all-purpose guidewires for everyday use in the cath lab. The REGATTA(TM) SB Guidewires are designed to facilitate access to side branches. The REGATTA(TM) HS Guidewires include features that ease placement in highly narrowed arteries. The different selections for each version refer to variations in tip type, tip profile, lateral support and/or wire length.
Professor Didier Carri, Rangueil, Toulouse, France, participated in a pre-market evaluation of the REGATTA (TM) Guidewire family under a range of challenging circumstances. He commented, "Regatta performed well in terms of steerability. On a very tortuous lesion it gave good trackability and torque response. The tip shape facilitated access to bifurcations. Cordis is able to offer the cath lab a strong and innovative choice of steerable guidewires "
The launch marks a major milestone in the company's efforts to offer a comprehensive product portfolio to meet the needs of physicians and their patients.
All versions in the REGATTA(TM) Guidewire family feature a next-generation hydrophilic coating technology that prevents swelling and a single-piece steel core wire that enhances torque. In addition, the REGATTA(TM) Guidewires and the REGATTA(TM) HS Guidewires offer a unique microridge design for additional torque control. The REGATTA(TM) HS Guidewires also feature a rounded wedge tip that facilitates the introduction of the wire in highly narrowed lesions, and the REGATTA(TM) SB Guidewires come with an innovative shaping ribbon that is oriented in the plane of a J-shape, helping physicians access side branches.
Cordis is the worldwide distributor of the REGATTA(TM) Guidewire family as a result of an agreement between Cordis and Brivant Limited signed in 2006.
About Cordis Corporation
Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in developing and manufacturing interventional vascular technology. Through the company's innovation, research and development, physicians worldwide are better able to treat the millions of patients who suffer from vascular disease. For more information, visit www.cordis.com.
Contacts: Teresa Mueller Cordis Corporation Office: +33-1-5500-4433 Mobile: +33-6-2736-6588 Email: tmueller1@jnjfr.jnj.com
Robert Mitchell Cordis EMEA Office: +32-2-352-1403 Mobile +44-(0)7976-514833 Email: rmitche4@crdbe.JNJ.com
Source: Cordis Corporation
|
|
|
|
|
See related product stories
|
|
|
|
|
|
|
|
|
|
| 
